ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

May 2, 2014

Survey Finds. Bush Signs Stopgap Funding Measure;

October 5, 2007

In Brief: Gaus Heads AHCPR; Lineberger Names New Leadership In Oncology and Clinical Research

July 22, 1994

In the Cancer Centers: Margaret Kripke of M.D. Anderson to Retire in 2007.

June 16, 2006